UncategorizedDenmark spawns the latest player in next-gen obesity drug development Empower Meds / November 25, 2025
UncategorizedHalia touts positive early data in trial of inflammation-targeting therapeutic Empower Meds / November 25, 2025
UncategorizedProtect and Rejuvenate Bio target canine heart disease – Longevity.Technology Empower Meds / November 25, 2025
UncategorizedHooke London and Citius Retreats partner to offer longevity programme – Longevity.Technology Empower Meds / November 25, 2025
UncategorizedAngitia lands $120m to advance osteoporosis therapeutics Empower Meds / November 25, 2025
UncategorizedNew $40m longevity biotech fund focuses on ‘radical life extension’ Empower Meds / November 25, 2025
UncategorizedTen Levels of Longevity: #4 longevity clinical services Empower Meds / November 25, 2025
UncategorizedEurope’s new €100m healthcare fund has strong longevity vibes Empower Meds / November 25, 2025
